TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio-Nord AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
137
|
133
|
114 |
| Financial expenses |
5
|
9
|
2 |
| Earnings before taxes |
-3
|
8
|
1 |
| EBITDA |
3
|
17
|
3 |
| Total assets |
180
|
89
|
178 |
| Current assets |
180
|
89
|
178 |
| Current liabilities |
171
|
76
|
169 |
| Equity capital |
6
|
10
|
6 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
3.3%
|
11.2%
|
3.4% |
| Turnover per employee |
46
|
44
|
38 |
| Profit as a percentage of turnover |
-2.2%
|
6.0%
|
0.9% |
| Return on assets (ROA) |
1.1%
|
19.1%
|
1.7% |
| Current ratio |
105.3%
|
117.1%
|
105.3% |
| Return on equity (ROE) |
-50.0%
|
80.0%
|
16.7% |
| Change turnover |
8
|
19
|
16 |
| Change turnover % |
7%
|
16%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.